3928 POINT EDEN WAY, HAYWARD, CA
COO Resignation - Jennifer Jarrett Steps Down from Arcus Biosciences
Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Material disclosure
Other Events
Arcus Biosciences Announces Public Offering of 13.7 Million Shares
Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
FY 2025
Q3
Q2
Q1
FY 2023
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Notice of Proposed Sale of Securities
Submission Upload
Correspondence